長寿・抗老化療法の世界市場レポート 2025年

長寿・抗老化療法市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.3％で383億6,000万米ドルに成長します。予測期間における成長の背景には、個別化医療に対する需要の高まり、AIを活用した健康診断への投資の増加、ウェルネス製品やアンチエイジング製品に対する消費者の関心の高まり、ナノテクノロジーと再生治療の融合、幹細胞治療の応用拡大などがあります。予測期間の主な動向には、遺伝子編集と幹細胞治療の統合、個別化ケアのためのウェアラブル健康技術の拡大、細胞の健康のための栄養補助食品の人気、標的アンチエイジング治療のためのナノ医療の進歩、バイオテクノロジーと再生医療の融合などが含まれます。

心血管疾患の罹患率の上昇が、今後数年間の長寿・抗老化療法市場の成長を牽引すると予想されます。心血管疾患の有病率は、肥満、糖尿病、座りがちなライフスタイル、食生活の乱れ、高齢化、慢性炎症など、さまざまな危険因子によって増加しています。長寿・抗老化療法は、加齢に関連した細胞障害を標的とし、心臓の健康全般を強化することによって、心血管疾患に対処することを目的としています。例えば、2022年8月に米国心臓病学会が発表した報告書によると、2025年から2060年の間に、米国における4大心血管系危険因子すべてが増加し、中でも糖尿病が39.3％と最も増加し、5,500万人に達すると予測されています。次いで脂質異常症（27.6％増の1億2,600万人）、高血圧（25.1％増の1億6,200万人）、肥満（18.3％増の1億2,600万人）が大幅に増加します。したがって、心血管疾患の有病率の増加は、長寿・抗老化療法市場の主要な促進要因です。

長寿・抗老化療法市場の有力企業は、抗老化製品の提供を進めるために戦略的提携を進めています。このようなパートナーシップは、組織が互いの強みとリソースを活用して共通の目的を達成し、競争力を高めることを可能にする協業契約です。例えば、2024年7月、米国を拠点とする投資持株会社MDBキャピタル・ホールディングスLLCは、非営利の医療・外科クリニックであるメイヨークリニックとパートナーシップを結び、抗老化プラットフォームを強化しました。この提携の目的は、老化や様々な疾患に関連する細胞老化を標的とした治療法を開発することです。この提携は、メイヨークリニックの臨床研究の専門知識とMDBキャピタルの革新的な医薬品開発アプローチを活用するもので、加齢に関連する疾患の患者の転帰を改善することを目的としています。このイニシアチブは、先進的な治療戦略を通じて老化の生物学的メカニズムに対処することへの注目が高まっていることを強調するものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界長寿・抗老化療法PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の長寿・抗老化療法市場：成長率分析
• 世界の長寿・抗老化療法市場の実績：規模と成長, 2019-2024
• 世界の長寿・抗老化療法市場の予測：規模と成長, 2024-2029, 2034F
• 世界長寿・抗老化療法総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の長寿・抗老化療法市場：セラピー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 老化抑制薬療法
• 遺伝子治療
• 細胞療法
• ミトコンドリア療法
• 免疫療法
• その他の治療法
• 世界の長寿・抗老化療法市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 長寿
• 老化抑制
• 心血管疾患
• 神経変性疾患
• 眼科疾患
• がん
• 世界の長寿・抗老化療法市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 医療機関
• 世界の長寿・抗老化療法市場老化抑制薬療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 低分子老化抑制薬
• 天然セノリティクス
• 老化細胞除去療法の併用
• 世界の長寿・抗老化療法市場遺伝子治療の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• CRISPRベースの遺伝子治療
• ウイルスベクター遺伝子治療
• RNA干渉療法
• 世界の長寿・抗老化療法市場細胞療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 幹細胞療法
• 免疫細胞療法
• 再生細胞療法
• 世界の長寿・抗老化療法市場ミトコンドリア療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ミトコンドリア補充療法
• ミトコンドリア強化化合物
• ミトコンドリア遺伝子治療
• 世界の長寿・抗老化療法市場免疫療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• モノクローナル抗体
• 免疫チェックポイント阻害剤
• 老化のためのワクチン
• 世界の長寿・抗老化療法市場その他の治療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ホルモン補充療法
• 栄養補助食品と栄養補助食品
• ライフスタイルと行動介入

第7章 地域別・国別分析

• 世界の長寿・抗老化療法市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の長寿・抗老化療法市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 長寿・抗老化療法市場：競合情勢
• 長寿・抗老化療法市場：企業プロファイル
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • BioAge Labs Overview, Products and Services, Strategy and Financial Analysis
  • Unity Biotechnology Overview, Products and Services, Strategy and Financial Analysis
  • Insilico Medicine Overview, Products and Services, Strategy and Financial Analysis
  • Human Longevity Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Calico Life Sciences LLC
• Recursion Pharmaceuticals
• AgeX Therapeutics Inc.
• Alkahest Inc.
• CohBar Inc.
• Stealth Bio Therapeutics
• Altos Labs
• Navitor Pharmaceuticals Inc.
• Sierra Sciences LLC
• T.A. Sciences Inc.
• Juvenescence AI Limited
• MDB Capital Holdings LLC
• Senex Biotechnology
• Spotlight Bioscience
• Prana Biotechnology Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 長寿・抗老化療法市場2029：新たな機会を提供する国
• 長寿・抗老化療法市場2029：新たな機会を提供するセグメント
• 長寿・抗老化療法市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Longevity and anti-senescence therapy encompass medical and scientific strategies aimed at extending human lifespan and promoting healthy aging by targeting the biological processes that contribute to aging, cellular damage, and a decline in bodily functions. These therapies focus on mitigating or reversing senescence, a process in which cells lose their ability to divide and function properly, contributing to aging and age-related diseases.

The primary types of longevity and anti-senescence therapies include senolytic drug therapy, gene therapy, cell therapy, mitochondrial therapy, immunotherapy, and others. Senolytic drug therapy specifically involves the use of medications designed to target and eliminate senescent cells, which have ceased to divide and contribute to aging and age-related diseases. This therapy is applied in areas such as longevity enhancement, senescence inhibition, cardiovascular diseases, neurodegenerative disorders, ophthalmic conditions, and cancer treatment, primarily by hospitals and medical service institutions.

The longevity and anti-senescence therapy market research report is one of a series of new reports from The Business Research Company that provides longevity and anti-senescence therapy market statistics, including longevity and anti-senescence therapy industry global market size, regional shares, competitors with a longevity and anti-senescence therapy market share, detailed longevity and anti-senescence therapy market segments, market trends and opportunities, and any further data you may need to thrive in the longevity and anti-senescence therapy industry. This longevity and anti-senescence therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The longevity and anti-senescence therapy market size has grown strongly in recent years. It will grow from $28.13 billion in 2024 to $29.99 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increasing life expectancy, rising awareness of preventive healthcare, breakthroughs in gene therapy, growth in regenerative medicine, and aging global populations.

The longevity and anti-senescence therapy market size is expected to see strong growth in the next few years. It will grow to $38.36 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to growing demand for personalized medicine, increasing investment in AI-powered health diagnostics, rising consumer interest in wellness and anti-aging products, the convergence of nanotechnology with regenerative therapies, and expanding applications of stem cell treatments. Major trends in the forecast period include the integration of gene editing and stem cell therapies, the expansion of wearable health tech for personalized care, the popularity of nutraceuticals for cellular health, advancements in nanomedicine for targeted anti-aging therapies, and the convergence of biotechnology with regenerative medicine.

The rising incidence of cardiovascular diseases is anticipated to drive the growth of the longevity and anti-senescence therapy market in the coming years. The prevalence of cardiovascular diseases is increasing due to various risk factors, including obesity, diabetes, sedentary lifestyles, poor diet, an aging population, and chronic inflammation. Longevity and anti-senescence therapies aim to address cardiovascular disease by targeting age-related cellular damage and enhancing overall heart health. For example, a report from the American College of Cardiology in August 2022 projected that between 2025 and 2060, all four major cardiovascular risk factors in the United States will rise, with diabetes expected to see the largest increase of 39.3%, reaching 55 million individuals. This will be followed by significant increases in dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). Therefore, the growing prevalence of cardiovascular diseases is a key driver for the longevity and anti-senescence therapy market.

Prominent companies in the longevity and anti-senescence therapy markets are pursuing strategic partnerships to advance their anti-senescence product offerings. These partnerships are collaborative agreements that enable organizations to leverage each other's strengths and resources to achieve shared objectives and enhance their competitive positions. For instance, in July 2024, MDB Capital Holdings LLC, a US-based investment holding company, formed a partnership with Mayo Clinic, a nonprofit medical and surgical clinic, to enhance its anti-senescence platform. The goal of this collaboration is to develop therapies targeting cellular senescence, which is linked to aging and various diseases. The partnership will utilize Mayo Clinic's clinical research expertise alongside MDB Capital's innovative drug development approach, aiming to improve patient outcomes for age-related conditions. This initiative underscores the increasing focus on addressing the biological mechanisms of aging through advanced therapeutic strategies.

In October 2023, Advantage Therapeutics Inc., a US-based company, acquired the intellectual property portfolio of Klogenix LLC for an undisclosed amount. This acquisition enhances Advantage Therapeutics' capabilities and increases its potential to develop impactful therapies for age-related diseases, thereby significantly improving patient outcomes in this vital healthcare sector. Klogenix LLC is a US-based provider of longevity and anti-senescence therapies.

Major companies operating in the longevity and anti-senescence therapy market are AbbVie Inc., BioAge Labs, Unity Biotechnology, Insilico Medicine, Human Longevity Inc., Calico Life Sciences LLC, Recursion Pharmaceuticals, AgeX Therapeutics Inc., Alkahest Inc., CohBar Inc., Stealth Bio Therapeutics, Altos Labs, Navitor Pharmaceuticals Inc., Sierra Sciences LLC, T.A. Sciences Inc., Juvenescence AI Limited, MDB Capital Holdings LLC, Senex Biotechnology, Spotlight Bioscience, Prana Biotechnology Ltd.

North America was the largest region in the longevity and anti-senescence therapy market in 2023. The regions covered in the longevity and anti-senescence therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the longevity and anti-senescence therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The longevity and anti-senescence therapy market consists of revenues earned by entities by providing services such as biomarker analysis, platelet-rich plasma (PRP) therapy, exosome therapy, bioidentical hormone replacement therapy, and anti-aging skin treatments. The market value includes the value of related goods sold by the service provider or included within the service offering. The longevity and anti-senescence therapy market also includes sales of peptide-based products, antioxidant and anti-inflammatory products, cognitive enhancers, and skincare and anti-aging cosmetics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Longevity And Anti-senescence Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on longevity and anti-senescence therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for longevity and anti-senescence therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The longevity and anti-senescence therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Therapy: Senolytic Drug Therapy; Gene Therapy; Cell Therapy; Mitochondrial Therapy; Immunotherapy; Other Therapies
• 2) By Application: Longevity; Senescence Inhibition; Cardiovascular Diseases; Neural Degenerative Diseases; Ophthalmology Disorders; Cancer
• 3) By End User: Hospital; Medical Service Institution
• Subsegments:
• 1) By Senolytic Drug Therapy: Small Molecule Senolytics; Natural Senolytics; Combination Senolytic Treatments
• 2) By Gene Therapy: CRISPR-Based Gene Therapy; Viral Vector Gene Therapy; RNA Interference Therapy
• 3) By Cell Therapy: Stem Cell Therapy; Immune Cell Therapy; Regenerative Cell Therapy
• 4) By Mitochondrial Therapy: Mitochondrial Replacement Therapy; Mitochondrial Enhancement Compounds; Mitochondrial Gene Therapy
• 5) By Immunotherapy: Monoclonal Antibodies; Immune Checkpoint Inhibitors; Vaccines For Aging
• 6) By Other Therapies: Hormone Replacement Therapy; Nutraceuticals And Dietary Supplements; Lifestyle And Behavioral Interventions
• Companies Mentioned: AbbVie Inc.; BioAge Labs; Unity Biotechnology; Insilico Medicine; Human Longevity Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Longevity And Anti-senescence Therapy Market Characteristics

3. Longevity And Anti-senescence Therapy Market Trends And Strategies

4. Longevity And Anti-senescence Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Longevity And Anti-senescence Therapy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Longevity And Anti-senescence Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Longevity And Anti-senescence Therapy Market Growth Rate Analysis
• 5.4. Global Longevity And Anti-senescence Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Longevity And Anti-senescence Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Longevity And Anti-senescence Therapy Total Addressable Market (TAM)

6. Longevity And Anti-senescence Therapy Market Segmentation

• 6.1. Global Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Senolytic Drug Therapy
• Gene Therapy
• Cell Therapy
• Mitochondrial Therapy
• Immunotherapy
• Other Therapies
• 6.2. Global Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Longevity
• Senescence Inhibition
• Cardiovascular Diseases
• Neural Degenerative Diseases
• Ophthalmology Disorders
• Cancer
• 6.3. Global Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Medical Service Institution
• 6.4. Global Longevity And Anti-senescence Therapy Market, Sub-Segmentation Of Senolytic Drug Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Small Molecule Senolytics
• Natural Senolytics
• Combination Senolytic Treatments
• 6.5. Global Longevity And Anti-senescence Therapy Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CRISPR-Based Gene Therapy
• Viral Vector Gene Therapy
• RNA Interference Therapy
• 6.6. Global Longevity And Anti-senescence Therapy Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stem Cell Therapy
• Immune Cell Therapy
• Regenerative Cell Therapy
• 6.7. Global Longevity And Anti-senescence Therapy Market, Sub-Segmentation Of Mitochondrial Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mitochondrial Replacement Therapy
• Mitochondrial Enhancement Compounds
• Mitochondrial Gene Therapy
• 6.8. Global Longevity And Anti-senescence Therapy Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibodies
• Immune Checkpoint Inhibitors
• Vaccines For Aging
• 6.9. Global Longevity And Anti-senescence Therapy Market, Sub-Segmentation Of Other Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hormone Replacement Therapy
• Nutraceuticals And Dietary Supplements
• Lifestyle And Behavioral Interventions

7. Longevity And Anti-senescence Therapy Market Regional And Country Analysis

• 7.1. Global Longevity And Anti-senescence Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Longevity And Anti-senescence Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Longevity And Anti-senescence Therapy Market

• 8.1. Asia-Pacific Longevity And Anti-senescence Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Longevity And Anti-senescence Therapy Market

• 9.1. China Longevity And Anti-senescence Therapy Market Overview
• 9.2. China Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Longevity And Anti-senescence Therapy Market

• 10.1. India Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Longevity And Anti-senescence Therapy Market

• 11.1. Japan Longevity And Anti-senescence Therapy Market Overview
• 11.2. Japan Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Longevity And Anti-senescence Therapy Market

• 12.1. Australia Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Longevity And Anti-senescence Therapy Market

• 13.1. Indonesia Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Longevity And Anti-senescence Therapy Market

• 14.1. South Korea Longevity And Anti-senescence Therapy Market Overview
• 14.2. South Korea Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Longevity And Anti-senescence Therapy Market

• 15.1. Western Europe Longevity And Anti-senescence Therapy Market Overview
• 15.2. Western Europe Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Longevity And Anti-senescence Therapy Market

• 16.1. UK Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Longevity And Anti-senescence Therapy Market

• 17.1. Germany Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Longevity And Anti-senescence Therapy Market

• 18.1. France Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Longevity And Anti-senescence Therapy Market

• 19.1. Italy Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Longevity And Anti-senescence Therapy Market

• 20.1. Spain Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Longevity And Anti-senescence Therapy Market

• 21.1. Eastern Europe Longevity And Anti-senescence Therapy Market Overview
• 21.2. Eastern Europe Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Longevity And Anti-senescence Therapy Market

• 22.1. Russia Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Longevity And Anti-senescence Therapy Market

• 23.1. North America Longevity And Anti-senescence Therapy Market Overview
• 23.2. North America Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Longevity And Anti-senescence Therapy Market

• 24.1. USA Longevity And Anti-senescence Therapy Market Overview
• 24.2. USA Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Longevity And Anti-senescence Therapy Market

• 25.1. Canada Longevity And Anti-senescence Therapy Market Overview
• 25.2. Canada Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Longevity And Anti-senescence Therapy Market

• 26.1. South America Longevity And Anti-senescence Therapy Market Overview
• 26.2. South America Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Longevity And Anti-senescence Therapy Market

• 27.1. Brazil Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Longevity And Anti-senescence Therapy Market

• 28.1. Middle East Longevity And Anti-senescence Therapy Market Overview
• 28.2. Middle East Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Longevity And Anti-senescence Therapy Market

• 29.1. Africa Longevity And Anti-senescence Therapy Market Overview
• 29.2. Africa Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Longevity And Anti-senescence Therapy Market Competitive Landscape And Company Profiles

• 30.1. Longevity And Anti-senescence Therapy Market Competitive Landscape
• 30.2. Longevity And Anti-senescence Therapy Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. BioAge Labs Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Unity Biotechnology Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Insilico Medicine Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Human Longevity Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Longevity And Anti-senescence Therapy Market Other Major And Innovative Companies

• 31.1. Calico Life Sciences LLC
• 31.2. Recursion Pharmaceuticals
• 31.3. AgeX Therapeutics Inc.
• 31.4. Alkahest Inc.
• 31.5. CohBar Inc.
• 31.6. Stealth Bio Therapeutics
• 31.7. Altos Labs
• 31.8. Navitor Pharmaceuticals Inc.
• 31.9. Sierra Sciences LLC
• 31.10. T.A. Sciences Inc.
• 31.11. Juvenescence AI Limited
• 31.12. MDB Capital Holdings LLC
• 31.13. Senex Biotechnology
• 31.14. Spotlight Bioscience
• 31.15. Prana Biotechnology Ltd.

32. Global Longevity And Anti-senescence Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Longevity And Anti-senescence Therapy Market

34. Recent Developments In The Longevity And Anti-senescence Therapy Market

35. Longevity And Anti-senescence Therapy Market High Potential Countries, Segments and Strategies

• 35.1 Longevity And Anti-senescence Therapy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Longevity And Anti-senescence Therapy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Longevity And Anti-senescence Therapy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer